
Biozen Drugs Private Limited
Manufacturer and distributor of pharmaceuticals, antibiotics, medicines, and dietary supplements.
Manufacturer and distributor of pharmaceuticals, antibiotics, medicines, and dietary supplements.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
-
U24232TG2013PTC087681
087681
Private Limited Indian Non-Government Company
16 May 2013
30 Sep 2017
31 Mar 2017
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Arithoti Naidu ![]() | Additional Director | 01-Oct-2017 | Current |
Mandati Kavitha ![]() | Additional Director | 01-Oct-2017 | Current |
Biozen Drugs Private Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 382.45% increase. The company also saw a substantial improvement in profitability, with a 385.1% increase in profit. The company's net worth Soared by an impressive increase of 48.35%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2017, Biozen Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Mandati Kavitha is a mutual person
Arithoti Naidu and Mandati Kavitha are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Biozen Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Biozen Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biozen Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Arithoti Raghurama Naidu was appointed as a Additional Director was appointed as a Additional Director on 01 Oct 2017 & has been associated with this company since 7 years 5 months .
Mandati Kavitha was appointed as a Additional Director was appointed as a Additional Director on 01 Oct 2017 & has been associated with this company since 7 years 5 months .
Biozen Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records.
Biozen Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Hyderabad.
Biozen Drugs Private Limited was registered on 16 May 2013 with Roc Hyderabad & aged 11 years 9 months as per MCA records.
Biozen Drugs Private Limited was incorporated on 16 May 2013.
The authorized share capital of Biozen Drugs Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Biozen Drugs Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Biozen Drugs Private Limited is 1-98/9/31 Flat No.101 Ramkuteer Opposite Lane To Chocolate Room Jaihind Enclave, Ayyappa Society India, Hyderabad, Telangana, 500085.
The corporate identification number (CIN) of Biozen Drugs Private Limited is U24232TG2013PTC087681 and the company number is 087681 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2015, the revenue trend for Biozen Drugs Private Limited has risen by 382.45%.
The financial reports for the fiscal year 2015 indicates that The net worth of Biozen Drugs Private Limited has experienced an upsurge of 48.35%.
The most recent Balance Sheet for Biozen Drugs Private Limited was filed with the ROC on 31 Mar 2017.
KH
PA
AR